Theodore R. Schroeder, President, CEO at CADENCE PHARMACEUTICALS INC (CADX), sold 30,000 shares at $9.76 ($293K) on 2009-12-31, disclosed to the SEC on 2010-01-04.
Scheduled sale ($293k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.76 | 19,657 | $192K | 65.4% |
| 2 | $9.80 | 10,343 | $101K | 34.6% |
| Total | $9.77 avg | 30,000 | $293K | 100% |
| Filing → |
| NBRV | BUY | 2019-08-28 | $90K | — | Filing → |
| CADX | BUY | 2011-05-17 | $120K | — | Filing → |
| CADX | SELL | 2010-10-04 | $418K | — | Filing → |